z-logo
Premium
Association between imaging response and survival following neoadjuvant chemotherapy in patients with resectable colorectal liver metastases: A cohort study
Author(s) -
Behrenbruch C.,
Prabhakaran S.,
Udayasiri D D.,
Michael M.,
Hollande F.,
Hayes I.,
Heriot A. G.,
Knowles B.,
Thomson B. N.
Publication year - 2021
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.26400
Subject(s) - medicine , hazard ratio , proportional hazards model , gastroenterology , colorectal cancer , chemotherapy , oncology , cohort , subgroup analysis , neoadjuvant therapy , confidence interval , cancer , breast cancer
Background The association between the imaging response (structural or metabolic) to neoadjuvant chemotherapy (neoCT) before colorectal liver metastasis (CRLM) and survival is unclear. Method A total of 201 patients underwent their first CRLM resection. A total of 94 (47%) patients were treated with neoCT. A multivariable, Cox proportional hazard regression analysis was performed to compare overall survival (OS) and progression‐free survival (PFS) between response groups. Results Multivariable regression analysis of the CT/MRI ( n  = 94) group showed no difference in survival (OS and PFS) in patients who had stable disease/partial response (SD/PR) or complete response (CR) versus patients who had progressive disease (PD) (OS: HR, 0.36 (95% CI: 0.11–1.19) p  = .094, HR, 0.78 (95% CI: 0.13–4.50) p  = .780, respectively), (PFS: HR, 0.70 (95% CI: 0.36–1.35) p  = .284, HR, 0.51 (0.18–1.45) p  = .203, respectively). In the FDG‐PET group ( n  = 60) there was no difference in the hazard of death for patients with SD/PR or CR versus patients with PD for OS or PFS except for the PFS in the small CR subgroup (OS: HR, 0.75 (95% CI: 0.11–4.88) p  = .759, HR, 1.21 (95% CI: 0.15–9.43) p  = .857), (PFS: HR, 0.34% (95% CI: 0.09–1.22), p  = .097, HR, 0.17 (95% CI: 0.04–0.62) p  = .008, respectively). Conclusion There was no convincing evidence of association between imaging response to neoCT and survival following CRLM resection.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here